Third Rock Ventures’ Post

Date/time: Wednesday, March 13 at 6pm CENTRAL   Registration link:  https://lnkd.in/eU7esi2C   Hosted by: University of Buffalo (Linda Harris) University of Texas (Mitchel Cox)   Articles: Comparison of clinical outcomes among patients with isolated axial vs muscular calf vein thrombosis: A systematic review and meta-analysis https://lnkd.in/eBityJkV   Safety and learning curve of percutaneous axillary artery access for complex endovascular aortic procedures https://lnkd.in/eVWa4j9G

DEIC 2023 (HEART FAILURE BRAZILIAN CONGRESS) -Among the BEST 3 clinical research papers in Congress 💗 I moderated a clinical case table of HFpEF (heart failure with preserved ejection fraction, discussing rare cardiomyopathies etiologies) I could also evaluate some posters and be evaluated. 🙌 #gratitude DEIC SBC #cardiologia #insuficienciacardiaca

Important study with Israeli company

Long-Term Clinical Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves CLD talks with Jay R. Khambhati, MD, Brigham and Women's Hospital / Harvard Medical School. In this study presented at TCT 2023, researchers compared longitudinal clinical outcomes in patients undergoing TAVR with balloon-expandable versus self-expanding valves in patients who received either therapy from 2014 to 2020. Read more: https://okt.to/y3aRlS

Long-Term Clinical Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves CLD talks with Jay R. Khambhati, MD, Brigham and Women's Hospital / Harvard Medical School. In this study presented at TCT 2023, researchers compared longitudinal clinical outcomes in patients undergoing TAVR with balloon-expandable versus self-expanding valves in patients who received either therapy from 2014 to 2020. Read more: https://okt.to/M5Isjh

A systematic review for the radiotherapeutic approach of Ventricular arrhythmias. Stereotactic arrhythmia radioablation as an alternative treatment approach has several fields of discussion and research originating from the current clinical study outcomes. https://lnkd.in/dzzpXKZ2

What an informative discussion on #HoLEP. Glad Richard Wolf Medical Instruments Corporation can help spread the word on this effective procedure for #BPH. #urology #urosome

Just hours ago, a paper detailing the two-year follow-up results of our Phase 1 clinical trial featuring CYP-001, our innovative Cymerus™ off-the-shelf iPSC-derived MSC product, was published in the prestigious Nature Medicine journal. This is the second paper published in Nature Medicine regarding this trial which reports survival rate compares very favourably to previously reported outcomes in SR-aGvHD - 60% vs. historical prognosis of below 20% two-year overall survival rate. “The publication of a second paper on this trial in such a high-impact journal is a testament to the importance of this project to the wider field of cellular therapy,” John Rasko AO, the international coordinating Principal Investigator for the trial. Read the full announcement here: https://bit.ly/3IhTz71 #stemcells #innovation #aGvHD #NatureMedicine #newsalert

"Saluda Medical has been on a journey to transform neuromodulation and solve large unmet clinical and health economic needs. The evidence presented at NANS demonstrates SmartLoop's capability to provide long-term superior outcomes for patients as well as advance SCS therapy efficiencies for clinical practices." Contact me for more info on how you can transform your practice with EVOKE from Saluda Medical!

What were the main scientific highlights and key learnings from #EuroPCR 2024, and what should you know about impact on practice? In this short session replay, Davide Capodanno summarises his key takeaways from this year's Course ➡ https://lnkd.in/d5XsMnQW (open access). Nieves Gonzalo Nicolas Dumonteil Thomas Cuisset #interventionalcardiology #clinicaltrials #latebreakingscience #trialupdates